BIOTRONIK SE & Co. KG controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile2 entries
2022
Second U.S. settlement over alleged improper payments
BIOTRONIK Inc. agreed to pay $12.95 million to resolve allegations that it caused false claims to be submitted to federal healthcare programs by providing remuneration to physicians to influence the use of cardiac devices. The allegations included excessive or low-value employee training sessions, lavish meals and events, international business-class travel, and conference honoraria. The Justice Department stated that the claims were allegations only and that the settlement was not a determination of liability.
2014
U.S. settlement over alleged physician kickbacks
The U.S. Department of Justice announced that BIOTRONIK Inc. would pay $4.9 million to resolve False Claims Act allegations that improper payments, expensive meals, and inflated advisory-board compensation were used to induce or reward physician use of BIOTRONIK pacemakers, defibrillators, and cardiac-resynchronization devices. The settlement resolved allegations and did not include an admission or judicial finding of liability.